From the Journals

Step counts under 5,000 still tied to lower mortality risk


 

FROM THE EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

Higher daily step counts were associated with reduced risk of all-cause mortality and cardiovascular (CV) mortality, with benefit beginning with any amount over about 4,000 and 2,300 steps, respectively, in a new meta-analysis.

More steps were better – additional benefit was seen with increasing increments of 500 or 1,000 steps.

Woman walking outdoors in Chicago, Leonardo Patrizi/E+/Getty Images

“One of our main aims was to overcome all the inconsistencies in previous studies, where the optimal number of daily steps for health benefits was usually between 6,000 and 10,000,” Maciej Banach, MD, PhD, of the Medical University of Lodz (Poland), said in an interview.

“As a preventive cardiologist, I saw that many of my patients were discouraged and said it’s impossible when I told them that making lifestyle changes included taking at least 7,000 daily steps,” he said.

“But our study in relatively healthy individuals, not patients, showed even a lower number – for example, around 4,000 – may be associated with a significant reduction of mortality.

“I tell people to start early, be regular, and don’t worry about the initial baseline number, because it’s important to start and it’s important to improve,” he said. “Our study showed that if we increase the number of steps per day, every 500- to 1,000-step increase might still be associated with an additional mortality reduction of 7%-15%.”

The study was published online in the European Journal of Preventive Cardiology.

Every move counts

The investigators searched the literature through June 2022 and selected 17 cohort studies with 226,889 participants and a median follow-up of 7.1 years for inclusion in the analysis: 10 studies reported all-cause mortality, 4 reported CV mortality, and 3 reported both outcomes.

The mean age of the participants was 64.4 years, and half were women. Daily step counts in the included studies were objectively measured for at least 7 consecutive days.

As noted, a 1,000-step increment was associated with a 15% decrease in risk of all-cause mortality (hazard ratio, 0.85); a 500-step increment was associated with a 7% decrease in CV mortality (HR, 0.93).

Compared with the reference quartile (median steps/day, 3,967), quartile 1 (median steps, 5,537) was associated with a 48% lower risk of all-cause mortality; quartile 2 (median steps, 7,370), with a 55% lower risk; and quartile 3 (median steps, 11,529), with a 67% risk reduction.

Similarly, compared with the lowest quartile of steps per day used as reference (median steps, 2,337), higher quartiles of steps per day (Q1, 3,982; Q2, 6,661; and Q3, 10,413) were linearly associated with a reduced risk of CV mortality (16%, 49%, and 77%, respectively).

In a restricted cubic splines model, a nonlinear dose-response association was observed between step count and all-cause and CV mortality, with a progressively lower risk of mortality with an increase in step count.

Dose-response curves were similar for men and women. However, there was a difference by age: Among people aged 60 years or older, the size of the risk reduction was smaller. Among the older adults, there was a 42% risk reduction for those who walked between 6000 and 10,000 steps daily, compared with a 49% reduction in risk among younger adults who walked between 7,000 and 13,000 steps a day.

For both groups, daily step counts higher than 5,000 resulted in a “dramatically” lower risk of all-cause mortality.

An analysis that compared the impact of climate regions on the associations showed no significant effect on all-cause mortality. People in all climate zones benefited when the daily step count exceeded approximately 5,500.

Even given the encouraging study results, “we know very well that every kind of exercise is critically important,” Dr. Banach said. It is easier to focus on step counts because the counts can be monitored and calculated with smartwatches, pedometers, and other tools. That also makes it easier to check associations and outcomes for large groups of patients.

“But in fact, we should not be focusing on one type of exercise, such as walking or running,” he said. “We can dance, ride bicycles, and do many other different exercises that mobilize our hearts.

“We also know that in all these activities, including steps, people have different capabilities – for example, some can walk more slowly, others faster and with more intensity.”

Dr. Banach recommended following the European and U.S. physical activity guidelines that advise, in addition to muscle-strengthening activities, 150 minutes of moderate-intensity aerobic training weekly, or 75 minutes of vigorous-intensity aerobic activity, or an equivalent combination of moderate- and vigorous-intensity aerobic activity.

From the results he sees in patients, he believes the combination approach is probably best for the heart.

Furthermore, it’s important to exercise regularly, something that’s easier if individuals enjoy what they’re doing. “The type of training or whether you are completely inactive or very active at the start doesn’t matter, because any improvement, any addition to the to the baseline values will have health benefits,” he concluded.

Pages

Recommended Reading

Daily statin cuts cardiovascular risk in HIV
Clinician Reviews
Research casts doubt on value of daily aspirin for healthy adults
Clinician Reviews
Exercise program boosted physical, but not mental, health in young children with overweight
Clinician Reviews
Daily aspirin for stroke prevention in healthy elderly should be avoided
Clinician Reviews
FDA clears AI-assisted colonoscopy device
Clinician Reviews
Even one drink a day tied to increased BP in healthy adults
Clinician Reviews
LAAO tied to fewer post-fall bleeds than DOACs in AF
Clinician Reviews
The best CRC screening test is still this one
Clinician Reviews
Older women risk overdiagnosis with mammograms: Study
Clinician Reviews
Sugary drinks may up risk for liver cancer, liver disease death
Clinician Reviews